Skip to main content
Top
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System

Authors: Ramsey A Lyimo, Jossy van den Boogaard, Elizabeth Msoka, Harm J Hospers, Andre van der Ven, Declare Mushi, Marijn de Bruin

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

An often-used tool to measure adherence to antiretroviral therapy (ART) is the Medication Event Monitoring System (MEMS), an electronic pill-cap that registers date and time of pill-bottle openings. Despite its strengths, MEMS-data can be compromised by inaccurate use and acceptability problems due to its design. These barriers remain, however, to be investigated in resource-limited settings. We evaluated the feasibility and acceptability of using MEMS-caps to monitor adherence among HIV-infected patients attending a rural clinic in Tanzania's Kilimanjaro Region.

Methods

Eligible patients were approached and asked to use the MEMS-caps for three consecutive months. Thereafter, qualitative, in-depth interviews about the use of MEMS were conducted with the patients. MEMS-data were used to corroborate the interview results.

Results

Twenty-three of the 24 patients approached agreed to participate. Apart from MEMS-use on travel occasions, patients reported no barriers regarding MEMS-use. Unexpectedly, the MEMS-bottle design reduced the patients' fear for HIV-status disclosure. Patients indicated that having their behavior monitored motivated them to adhere better. MEMS-data showed that most patients had high levels of adherence and there were no bottle-openings that could not be accounted for by medication intake. Non-adherence in the days prior to clinic visits was common and due to the clinic dispensing too few pills.

Conclusion

MEMS-bottle use was readily accepted by patients. Although the MEMS-bottle was used accurately by most patients, patients need to be more explicitly instructed to continue MEMS-use when travelling. Even HIV-clinics with sufficient staff and free medication may impose structural adherence barriers by supplying an insufficient amount of pills.
Appendix
Available only for authorised users
Literature
1.
go back to reference United Nations Programme on HIV/AIDS: AIDS Epidemic update UNAIDS/09.36E/JC1700E. Geneva. 2009 United Nations Programme on HIV/AIDS: AIDS Epidemic update UNAIDS/09.36E/JC1700E. Geneva. 2009
2.
go back to reference World Health Organization: Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector. Geneva. 2009 World Health Organization: Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector. Geneva. 2009
3.
go back to reference Tanzania Commission for AIDS: Tanzania 2007-08 HIV and Malaria Indicator Survey. Dar es Salaam. 2009 Tanzania Commission for AIDS: Tanzania 2007-08 HIV and Malaria Indicator Survey. Dar es Salaam. 2009
4.
go back to reference UNGASS/TACAIDS: UNGASS Reporting for 2010: Tanzania Mainland and Zanzibar. Tanzania. 2010 UNGASS/TACAIDS: UNGASS Reporting for 2010: Tanzania Mainland and Zanzibar. Tanzania. 2010
5.
go back to reference World Health Organization: Adherence to long term therapy: Evidence for action. Geneva. 2003 World Health Organization: Adherence to long term therapy: Evidence for action. Geneva. 2003
6.
go back to reference Lucas GM: Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. J Antimicrob Chemother. 2005, 55: 413-416. 10.1093/jac/dki042.CrossRefPubMed Lucas GM: Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. J Antimicrob Chemother. 2005, 55: 413-416. 10.1093/jac/dki042.CrossRefPubMed
7.
go back to reference Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al: Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001, 15: 1181-1183. 10.1097/00002030-200106150-00015.CrossRefPubMed Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al: Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001, 15: 1181-1183. 10.1097/00002030-200106150-00015.CrossRefPubMed
8.
go back to reference Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999, 21: 1074-1090. 10.1016/S0149-2918(99)80026-5.CrossRefPubMed Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999, 21: 1074-1090. 10.1016/S0149-2918(99)80026-5.CrossRefPubMed
9.
go back to reference Wu AW, Ammassari A, Antinori A: Adherence to antiretroviral therapy: where are we, and where do we go from here?. J Acquir Immune Defic Syndr. 2002, 31 (Suppl 3): S95-S97.CrossRefPubMed Wu AW, Ammassari A, Antinori A: Adherence to antiretroviral therapy: where are we, and where do we go from here?. J Acquir Immune Defic Syndr. 2002, 31 (Suppl 3): S95-S97.CrossRefPubMed
10.
go back to reference Bova CA, Fennie KP, Knafl GJ, Dieckhaus KD, Watrous E, Williams AB: Use of Electronic Monitoring Devices to Measure Antiretroviral Adherence: Practical Considerations. AIDS Behav. 2005, 9: 103-110. 10.1007/s10461-005-1685-0.CrossRefPubMed Bova CA, Fennie KP, Knafl GJ, Dieckhaus KD, Watrous E, Williams AB: Use of Electronic Monitoring Devices to Measure Antiretroviral Adherence: Practical Considerations. AIDS Behav. 2005, 9: 103-110. 10.1007/s10461-005-1685-0.CrossRefPubMed
11.
go back to reference Deschamps AE, de GS, Vandamme AM, Bobbaers H, Peetermans WE, van WE: Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS. 2008, 22: 735-743. 10.1089/apc.2007.0229.CrossRefPubMed Deschamps AE, de GS, Vandamme AM, Bobbaers H, Peetermans WE, van WE: Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS. 2008, 22: 735-743. 10.1089/apc.2007.0229.CrossRefPubMed
12.
go back to reference Mbonu NC, Van den Borne B, De Vries NK: Stigma of People with HIV/AIDS in Sub-Saharan Africa: A Literature Review. Journal of Tropical Medicine. 2009 Mbonu NC, Van den Borne B, De Vries NK: Stigma of People with HIV/AIDS in Sub-Saharan Africa: A Literature Review. Journal of Tropical Medicine. 2009
13.
go back to reference Berg KM, Arnsten JH: Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006, 43 (Suppl 1): S79-S87.CrossRefPubMedPubMedCentral Berg KM, Arnsten JH: Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006, 43 (Suppl 1): S79-S87.CrossRefPubMedPubMedCentral
14.
go back to reference Wagner GJ, Ghosh-Dastidar B: Electronic monitoring: adherence assessment or intervention?. HIV Clin Trials. 2002, 3: 45-51. 10.1310/XGXU-FUDK-A9QT-MPTF.CrossRefPubMed Wagner GJ, Ghosh-Dastidar B: Electronic monitoring: adherence assessment or intervention?. HIV Clin Trials. 2002, 3: 45-51. 10.1310/XGXU-FUDK-A9QT-MPTF.CrossRefPubMed
15.
go back to reference Bell DJM, Kapitao YDM, Sikwese R, van Oosterhout JJM, Lalloo DGF: Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr. 2007, 45 (5): 560-563. 10.1097/QAI.0b013e3180decadb.CrossRefPubMed Bell DJM, Kapitao YDM, Sikwese R, van Oosterhout JJM, Lalloo DGF: Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr. 2007, 45 (5): 560-563. 10.1097/QAI.0b013e3180decadb.CrossRefPubMed
16.
go back to reference Bilker Robert Gross, Bilker Warren B, Friedman Harvey M, Strom Brian L: Effect of Adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 2001. 2001, 15 (16): 2109-2117. Bilker Robert Gross, Bilker Warren B, Friedman Harvey M, Strom Brian L: Effect of Adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 2001. 2001, 15 (16): 2109-2117.
17.
go back to reference Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ: Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001, 35: 1010-1015. 10.1345/aph.10349.CrossRefPubMed Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ: Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001, 35: 1010-1015. 10.1345/aph.10349.CrossRefPubMed
18.
go back to reference Konkle-Parker DJ, Erlen JA, Dubbert PM: Lessons learned from an HIV adherence pilot study in the Deep South. Patient Educ Couns. 2010, 78: 91-96. 10.1016/j.pec.2009.04.010.CrossRefPubMed Konkle-Parker DJ, Erlen JA, Dubbert PM: Lessons learned from an HIV adherence pilot study in the Deep South. Patient Educ Couns. 2010, 78: 91-96. 10.1016/j.pec.2009.04.010.CrossRefPubMed
19.
go back to reference Safren SA, Kumarasamy N, Hosseinipour M, Harwood MM, Hoffman I, McCauley M, et al: Perceptions about the acceptability of assessments of HIV medication adherence in Lilongwe, Malawi and Chennai, India. AIDS Behav. 2006, 10: 443-450. 10.1007/s10461-006-9094-6.CrossRefPubMed Safren SA, Kumarasamy N, Hosseinipour M, Harwood MM, Hoffman I, McCauley M, et al: Perceptions about the acceptability of assessments of HIV medication adherence in Lilongwe, Malawi and Chennai, India. AIDS Behav. 2006, 10: 443-450. 10.1007/s10461-006-9094-6.CrossRefPubMed
20.
go back to reference Shellmer DA, Zelikovsky N: The challenges of using medication event monitoring technology with pediatric transplant patients. Pediatr Transplant. 2007, 11: 422-428. 10.1111/j.1399-3046.2007.00681.x.CrossRefPubMedPubMedCentral Shellmer DA, Zelikovsky N: The challenges of using medication event monitoring technology with pediatric transplant patients. Pediatr Transplant. 2007, 11: 422-428. 10.1111/j.1399-3046.2007.00681.x.CrossRefPubMedPubMedCentral
21.
go back to reference King R, Katuntu D, Lifshay J, Packel L, Batamwita R, Nakayiwa S, et al: Processes and outcomes of HIV serostatus disclosure to sexual partners among people with HIV in Uganda. AIDS Behav. 2008, 12 (2): 232-243. 10.1007/s10461-007-9307-7.CrossRefPubMed King R, Katuntu D, Lifshay J, Packel L, Batamwita R, Nakayiwa S, et al: Processes and outcomes of HIV serostatus disclosure to sexual partners among people with HIV in Uganda. AIDS Behav. 2008, 12 (2): 232-243. 10.1007/s10461-007-9307-7.CrossRefPubMed
22.
go back to reference Mutalemwa P, Kisoka W, Nyigo V, Barongo V, Malecela MN, Kisinza WN: Manifestations and reduction strategies of stigma and discrimination on people living with HIV/AIDS in Tanzania. Tanzania Journal of Health Research. 2008, 10 (4): 220-225.PubMed Mutalemwa P, Kisoka W, Nyigo V, Barongo V, Malecela MN, Kisinza WN: Manifestations and reduction strategies of stigma and discrimination on people living with HIV/AIDS in Tanzania. Tanzania Journal of Health Research. 2008, 10 (4): 220-225.PubMed
23.
go back to reference Deschamps AE, Graeve VD, van WE, De S, Vandamme AM, van VK, et al: Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care STDS. 2004, 18: 644-657. 10.1089/apc.2004.18.644.CrossRefPubMed Deschamps AE, Graeve VD, van WE, De S, Vandamme AM, van VK, et al: Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care STDS. 2004, 18: 644-657. 10.1089/apc.2004.18.644.CrossRefPubMed
24.
go back to reference Deschamps AE, van WE, Denhaerynck K, de GS, Vandamme AM: Use of electronic monitoring induces a 40-day intervention effect in HIV patients. J Acquir Immune Defic Syndr. 2006, 43: 247-248.CrossRefPubMed Deschamps AE, van WE, Denhaerynck K, de GS, Vandamme AM: Use of electronic monitoring induces a 40-day intervention effect in HIV patients. J Acquir Immune Defic Syndr. 2006, 43: 247-248.CrossRefPubMed
Metadata
Title
Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System
Authors
Ramsey A Lyimo
Jossy van den Boogaard
Elizabeth Msoka
Harm J Hospers
Andre van der Ven
Declare Mushi
Marijn de Bruin
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-92

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue